Yeji
NDA/BLA filedoutcome: unknownconf 0.95

kresladi — NDA/BLA filed

$RCKT · ROCKET PHARMACEUTICALS, INC. · Treatment of pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) due to biallelic variants in ITGB2 without an available human leukocyte antigen-matched sibling donor for allogeneic hematopoietic stem cell transplant
Event date
October 2, 2023
978 days ago
Sponsor runway
10 mo
$144.4M liquid

Evidence

On October 2, 2023, Rocket Pharmaceuticals, Inc. (the
Source: 8-K filed 2023-10-02View on EDGAR ↗0001140361-23-046302

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$RCKTkresladi2025-10-14unknown

Recent insider activity· ±90 days

6 insiders · 1 buys · 8 sells
Pre-catalyst buying:RTW INVESTMENTS, LP bought $50.00M in the 30 days before this event
Grant
2023-12-07
Woods Keith
Director
11,960 @
Grant
2023-12-07
Woods Keith
Director
20,522 @
Sell
2023-11-15
Makker Gotham
Director
20,000 @ $22.53$451K
Exercise
2023-11-14
Militello John
See Remarks
725 @
Exercise
2023-11-14
Patel Kinnari
See Remarks
3,989 @
Exercise
2023-11-14
Shah Gaurav
CEO
7,979 @
Sell
2023-10-20
Militello John
See Remarks
564 @ $17.06$10K
Exercise
2023-10-05
Patel Kinnari
See Remarks
3,333 @
Sell
2023-09-29
Makker Gotham
Director
4,677 @ $21.14$99K
Sell
2023-09-28
Makker Gotham
Director
10,312 @ $21.03$217K
Buy
2023-09-15
RTW INVESTMENTS, LP
Director
3,126,955 @ $15.99$50.00M
Other
2023-08-28
RTW INVESTMENTS, LP
Director
500,000 @ $22.05$11.03M
Other
2023-08-28
RTW INVESTMENTS, LP
Director
1 @
Sell
2023-08-17
Patel Kinnari
See Remarks
1,534 @ $15.47$24K
Sell
2023-08-17
Militello John
See Remarks
284 @ $15.47$4K
Sell
2023-08-17
Shah Gaurav
CEO
4,767 @ $15.47$74K
Exercise
2023-08-14
Militello John
See Remarks
725 @
Exercise
2023-08-14
Shah Gaurav
CEO
7,979 @
Exercise
2023-08-14
Patel Kinnari
See Remarks
3,989 @
Sell
2023-07-20
Militello John
See Remarks
573 @ $19.03$11K
Exercise
2023-07-18
Militello John
See Remarks
1,586 @